when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog news

Browse

1,236 stories matching this filter · ← front page

★ save view ↓export CSV

rangeto

sort

recent oldest source alpha

source

STAT814 Endpoints614 BioPharma Dive237 onclive165 Fierce Biotech82 BioSpace79 raps32 globenewswire health

therapy area

all Oncology81 Cardiology27 Psychiatry & CNS21 Vaccines17 Immunology17 Rare Disease12 Hepatology

From confidence to capital: Positioning biotech for the next growth cycle
How can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.
BioPharma Dive · 2d agoRegulatoryNeutral↗ source
Opinion: How midwives like me can help fight medical misinformation
“I have come to believe that changing a mind is rarely the point. Planting a seed is,” writes nurse-midwife Mara Evans.
STAT · 2d agoRegulatoryNeutral↗ source

page 3 of 50

26

6

Infectious Disease4

STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities

Even as some medical schools heed health secretary Robert F. Kennedy Jr.’s call for more nutrition education, several told STAT that they plan to steer clear of topics that aren’t…

STAT · 2d agoRegulatoryNeutral↗ source

Opinion: E-bikes, e-scooters are a burgeoning pediatric public health emergency

“Emergency departments across America report dramatic increases in serious injuries from e-bikes and e-scooters,” write CHOP’s J. Todd R. Lawrence and Madison A. Kesler.

STAT · 2d agoRegulatoryNeutral↗ source

FDA panel backs compounding of epitalon, rejects emideltide in narrow vote

The FDA advisory committee voted to allow compounding pharmacies to produce the peptide epitalon, while narrowly voting against allowing the production of emideltide. The decision follows the pane…

STAT · 5d agoRegulatoryNeutral↗ source

U.S. measles cases in 2026 already exceed total from record-breaking 2025 year

The CDC reports 2,318 measles cases in the United States so far in 2026, surpassing the 2,289 cases recorded for the entire year of 2025. The increase makes 2026 the worst measles year since 1991,…

STAT · 5d agoNeutral↗ source

Rigel Pharmaceuticals appoints Alison Hannah as executive vice president and chief medical officer

Rigel Pharmaceuticals announced that it has hired Alison Hannah to serve as executive vice president and chief medical officer. Hannah joins Rigel after holding the same senior medical leadership…

STAT · 5d agoPositive↗ source

Former FDA food safety chief warns nutrition push may overlook cyclospora outbreak risks

Susan Mayne, who led the FDA’s Center for Food Safety and Applied Nutrition from 2015 to 2023, argues that nutrition and food safety cannot be treated separately. She says the two are linked and bo…

STAT · 5d agoNeutral↗ source

Sanofi halts development of troubled immune drug in eczema

The decision to no longer seek approval of amlitelimab is the latest setback for a treatment once hailed as a future blockbuster. One analyst expects Sanofi to now pursue “strategic action” to boos…

BioPharma Dive · 5d ago↗ source

STAT+: Fatal gene-editing trial in China raises ethics and oversight questions

Sanofi insulin pen in short supply, a win for peptide compounds, and more biotech news from The Readout

STAT · 5d ago↗ source

STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more

In a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the drugs

STAT · 5d ago↗ source

Novo escalates legal fight with Lilly; J&J reinforces ‘dominance’ in multiple myeloma

Novo is seeking an injunction that would halt allegedly “misleading” obesity drug ads. Elsewhere, the FDA began reviewing a highly anticipated medicine and a veteran investor landed at an AI startup.

BioPharma Dive · 5d ago↗ source

A new, separate outbreak of the diarrhea-causing parasite

A win for peptide proponents, autism advisory committees clash, and more health news from Morning Rounds

STAT · 5d ago↗ source

STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill

Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.

STAT · 5d ago↗ source

Opinion: I may be one of the last middle-class medical students who could afford to become a doctor

A federal loan program made it possible for Gauri Gurumurthy to pursue medicine. Now that program is changing.

STAT · 5d ago↗ source

Opinion: The U.S. pharmaceutical supply chain problem is not about China

The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes Pooja Yerramilli.

STAT · 5d ago↗ source

Senate advances MAHA-friendly bill for food warning labels and junk food ad bans

Unexpected alliances among Republicans and Democrats were on display over a bill meant to rein in ultra-processed foods.

STAT · 5d ago↗ source

STAT+: White House offers its science blueprint: More AI, less life sciences

The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of research dollars from universities to industry.

STAT · 5d ago↗ source

Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter

July 24, 2026 - Taoyuan City, Taiwan - Sunny Pharmtech, Inc is voluntarily recalling three lots of Cyclophosphamide for Injection, USP, 1g/vial and 2g/vial, to the User Level due to the presence of…

fda recalls · 5d ago↗ source

BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION

July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter…

fda recalls · 5d ago↗ source

American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter

July 24, 2026 – Shirley, NY, American Regent, Inc. is conducting a nationwide voluntary recall of a single lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL single dose vial to the consume…

fda recalls · 5d ago↗ source

LIDL US Recalls Eridanous Shortbread Cookies with Chocolate Truffle Coating & Apricot Filling due to Undeclared Wheat, Soy, Milk, and Eggs

ARLINGTON, VA – JULY 24, 2026 – Lidl US is recalling all units of Eridanous Shortbread Cookies with Chocolate Truffle Coating & Apricot Filling 11.6 oz (330 g) box UPC 4056489125839 with foreign la…

fda recalls · 5d ago↗ source

Scribe secures $129M in a rare gene editing IPO

The startup is the first gene editing company to price an IPO in more than two years, though it banked far less than most other biotechs that have gone public in 2026.

BioPharma Dive · 5d ago↗ source

FDA panel endorses broader use of certain peptides

In a victory for Robert F. Kennedy Jr.’s “MAHA” agenda, panelists narrowly recommended broader use of six of the seven peptides up for consideration despite a lack of substantive evidence supportin…

BioPharma Dive · 5d ago↗ source

STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides

The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.

STAT · 6d ago↗ source